Literature DB >> 10377363

Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation.

T J Collier1, C E Sortwell, B F Daley.   

Abstract

We examined the behavioral and morphological correlates of the response to a single intrastriatal dispersed cell graft of fetal rat ventral mesencephalic tissue in male Fischer-344 rats of varying age (4, 17, and 24-26 months old) and history of mesostriatal dopamine (DA) depletion (1 or 14 months). Our goal was to determine the impact of advancing age and duration of DA depletion in the host on DA graft viability and function. The findings can be summarized as follows. (1) Fetal DA neuron grafts that were effective in completely ameliorating amphetamine-induced rotational behavior in young rats with short-term lesions were virtually without effect in aged rats with long-term lesions. Middle-aged rats with long-term lesions responded to these grafts with partial behavioral recovery. (2) Age of the host at the time of transplantation, and not duration of DA depletion, was the primary determinant of response to DA grafts. (3) Diminished efficacy of grafts in lesioned aging rats was related to decreased survival and neurite extension of transplanted DA neurons. (4) Co-grafts of DA neurons with Schwann cells as a source of neurotrophic support improved the behavioral outcome of grafts in aged lesioned rats. These findings support the view that the DA-depleted striatum of aged rats is an impoverished environment for survival, growth, and function of DA grafts. Consistent with this view, local supplementation of the neurotrophic environment of grafted DA neurons with products of co-grafted Schwann cells, a demonstrated source of neurotrophic activity for embryonic DA neurons, improved graft outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377363      PMCID: PMC6782306     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease.

Authors:  P Brundin; R E Strecker; O Lindvall; O Isacson; O G Nilsson; G Barbin; A Prochiantz; C Forni; A Nieoullon; H Widner
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

2.  Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.

Authors:  G Chadi; Y Cao; R F Pettersson; K Fuxe
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

Review 3.  Dopamine cell replacement: Parkinson's disease.

Authors:  D M Yurek; J R Sladek
Journal:  Annu Rev Neurosci       Date:  1990       Impact factor: 12.449

4.  Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.

Authors:  J H Kordower; J M Rosenstein; T J Collier; M A Burke; E Y Chen; J M Li; L Martel; A E Levey; E J Mufson; T B Freeman; C W Olanow
Journal:  J Comp Neurol       Date:  1996-06-24       Impact factor: 3.215

5.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.

Authors:  J H Kordower; T B Freeman; B J Snow; F J Vingerhoets; E J Mufson; P R Sanberg; R A Hauser; D A Smith; G M Nauert; D P Perl
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

6.  Intracerebral grafting of neuronal cell suspensions. VIII. Survival and growth of implants of nigral and septal cell suspensions in intact brains of aged rats.

Authors:  F H Gage; A Björklund; U Stenevi; S B Dunnett
Journal:  Acta Physiol Scand Suppl       Date:  1983

7.  Changes in monoamines and their metabolite levels in some brain regions of aged rats.

Authors:  F Ponzio; G Calderini; G Lomuscio; G Vantini; G Toffano; S Algeri
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

8.  Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

Authors:  T B Freeman; C W Olanow; R A Hauser; G M Nauert; D A Smith; C V Borlongan; P R Sanberg; D A Holt; J H Kordower; F J Vingerhoets
Journal:  Ann Neurol       Date:  1995-09       Impact factor: 10.422

9.  Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain.

Authors:  C H Misra; H Shelat; R C Smith
Journal:  Eur J Pharmacol       Date:  1981-12-17       Impact factor: 4.432

10.  Co-grafts of embryonic dopamine neurons and adult sciatic nerve into the denervated striatum enhance behavioral and morphological recovery in rats.

Authors:  T J Collier; J E Springer
Journal:  Exp Neurol       Date:  1991-12       Impact factor: 5.330

View more
  24 in total

Review 1.  Imaging in cell-based therapy for neurodegenerative diseases.

Authors:  Deniz Kirik; Nathalie Breysse; Tomas Björklund; Laurent Besret; Philippe Hantraye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

3.  Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain.

Authors:  Nicole K Polinski; Sara E Gombash; Fredric P Manfredsson; Jack W Lipton; Christopher J Kemp; Allyson Cole-Strauss; Nicholas M Kanaan; Kathy Steece-Collier; Nathan C Kuhn; Susan L Wohlgenant; Caryl E Sortwell
Journal:  Neurobiol Aging       Date:  2014-10-13       Impact factor: 4.673

4.  Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration.

Authors:  D Kirik; C Winkler; A Björklund
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  Progressive reparative gliosis in aged hosts and interferences with neural grafts in an animal model of Huntington's disease.

Authors:  Yvona Mazurová; Ivan Látr; Jan Osterreicher; Ivana Guncová
Journal:  Cell Mol Neurobiol       Date:  2006-06-14       Impact factor: 5.046

6.  Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

Authors:  Kathy Steece-Collier; David J Rademacher; Katherine Soderstrom
Journal:  Basal Ganglia       Date:  2012-02-11

7.  Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

Authors:  Timothy J Collier; Jennifer O'Malley; David J Rademacher; Jennifer A Stancati; Kellie A Sisson; Caryl E Sortwell; Katrina L Paumier; Kibrom G Gebremedhin; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

8.  Blueberry supplementation attenuates microglial activation in hippocampal intraocular grafts to aged hosts.

Authors:  Lauren M Willis; Linnea Freeman; Paula C Bickford; E Matthew Quintero; Claudia D Umphlet; Alfred B Moore; Laura Goetzl; Ann-Charlotte Granholm
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

9.  Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

Authors:  Brian T Terpstra; Timothy J Collier; Deanna M Marchionini; Nathan D Levine; Katrina L Paumier; Caryl E Sortwell
Journal:  J Neurosci Methods       Date:  2007-07-01       Impact factor: 2.390

10.  Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.

Authors:  J W Dickerson; A M Hemmerle; S Numan; K H Lundgren; K B Seroogy
Journal:  Neuroscience       Date:  2009-06-06       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.